European Commission Investigates Sanofi for Potential Antitrust Breaches
Sanofi is facing scrutiny from the European Commission over allegations of antitrust violations linked to a misleading campaign about a flu vaccine.
Editorial Staff
1 min read
Updated 3 days ago
The European Commission has launched an investigation into Sanofi, focusing on potential breaches of antitrust regulations.
The inquiry centers on claims that Sanofi conducted a misleading campaign regarding a flu vaccine, which may have impacted competition.
As the investigation unfolds, the implications for Sanofi and the broader pharmaceutical market remain to be seen.
Updates
Update at 12:29 UTC on 2026-06-26
STAT reported The European Commission is investigating Sanofi for allegedly breaching antitrust rules by running a “misleading” campaign about a flu vaccine.
Sources: STAT